3-OME-GAG acts as a cap analogue. The product is utilized for transcription with the starting sequence 5'AG3', and cap1 transcription capping produces the natural cap1 structure.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.